Bank of America Corp DE Increases Stock Position in Option Care Health, Inc. $OPCH

Key Points

• Bank of America increased its Option Care Health stake by 14.6% in the first quarter, adding 247,766 shares to own approximately 1.24% of the company, valued at $52.36 million.
• Institutional ownership remains high at 98.05%, with several major investors—including Durable Capital Partners, Norges Bank and Sumitomo Mitsui Trust Group—building or initiating positions.
• Option Care Health exceeded quarterly earnings and revenue estimates, reporting $0.45 EPS and $1.44 billion in revenue, while analysts maintain a consensus “Hold” rating and a $29.92 price target versus the stock’s $24.08 price.

Bank of America Corp DE grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,945,015 shares of the company's stock after purchasing an additional 247,766 shares during the period. Bank of America Corp DE owned approximately 1.24% of Option Care Health worth $52,360,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of OPCH. Durable Capital Partners LP grew its holdings in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP acquired a new stake in Option Care Health in the fourth quarter valued at $95,580,000. Sumitomo Mitsui Trust Group Inc. acquired a new stake in Option Care Health in the first quarter valued at $70,287,000. Norges Bank purchased a new stake in shares of Option Care Health during the 4th quarter worth $61,787,000. Finally, Van Berkom & Associates Inc. purchased a new stake in shares of Option Care Health during the 1st quarter worth $42,739,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Down 1.7%

Shares of NASDAQ OPCH opened at $24.08 on Wednesday. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80. The company has a market capitalization of $3.61 billion, a PE ratio of 18.11, a price-to-earnings-growth ratio of 1.42 and a beta of 0.65. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The firm's 50-day moving average is $21.88 and its two-hundred day moving average is $26.17.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.Option Care Health's revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OPCH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. cut their price target on shares of Option Care Health from $40.00 to $33.00 and set an "overweight" rating for the company in a report on Monday, May 4th. Stephens reissued an "equal weight" rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Barrington Research lowered their target price on shares of Option Care Health from $42.00 to $32.00 and set an "outperform" rating on the stock in a research report on Friday, May 1st. Morgan Stanley set a $28.00 target price on shares of Option Care Health in a report on Wednesday, May 6th. Finally, Wall Street Zen upgraded shares of Option Care Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 1st. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $29.92.

Option Care Health Company Profile

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source